Medline stock

MDLN · NASDAQ · USD

Compare Medline
$37.68Change from previous close: −3.80%Absolute change: −$1.49

Close · November 17, 2026

Price history

−8.52% over the period

Full history: from $41.65 (December 19, 2025) to $38.10 (November 17, 2026), −8.52%.

Show chart data

Closing prices adjusted for splits: the last close of each month.

DateClose
November 17, 2026$38.10
October 30, 2026$32.12
September 25, 2026$34.70
August 28, 2026$35.28
July 31, 2026$39.28
June 26, 2026$38.87
May 29, 2026$36.56
April 24, 2026$44.76
March 27, 2026$41.36
February 27, 2026$47.51
January 30, 2026$44.20
December 26, 2025$44.13
December 19, 2025$41.65

At a glance

  • The company

    Manufactures and distributes medical-surgical products and provides supply chain solutions for hospitals, surgery centers and healthcare facilities in the US and internationally

  • Latest results

    Quarter to September 30, 2026 · EPS $0.44 (estimate $0.35)

TickerLandia's take on Medline

Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks

Where the price stands

52-wk low$31.49
52-wk high$50.88

−25.94% from the 52-week high

Analysts · 27 analysts

Average target$44.31+17.59% vs. price

Buy 23 · Hold 4 · Sell 0 · Buy

TickerLandia Fingerprint: Medline

Compared with similar companies: very low profitability and very high growth.

Financials and price compared with 34 companies in the medical instruments & supplies industry, worldwide. Momentum and risk compared with 883 North American stocks.

Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 18, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated

Valuation

Medline is in line with similar companies

Medline's P/E (trailing 12 months): 40.2, in line with the median of a group of 9 similar companies (40.2).

Compared with 9 similar companies

Medline's metrics compared with similar companies
MetricMedlinePosition in the groupBand
P/E (trailing 12 months)40.2Middle
Forward P/E26.2Middle
Operating margin5.0%Low
ROE4.9%Middle
Debt/equity0.66High

Grey band: the middle half of the group; tick: the median; dot: Medline. All multiples and dividends

TickerLandia analysisHow it is calculated

The financials

The business in numbers

Revenue

$7.69B

Latest quarter · Q2 2026

Net income

$60M

Latest quarter · Q2 2026

Quarterly net margin

0.8%

Latest quarter · Q2 2026

Numbers and valuation

Full valuation
Market cap
$42.57B
P/E
40.2
EPS
$0.65
Volume
10.65M
Daily trading
€364.21M

How Medline is changing

All results
  • Revenue grew 9.9% a year on average over the last 3 years

  • Operating margin rose from 4.0% to 7.7%

  • Profits turn into cash: free cash flow equal to 157% of net income

Returns

Medline returns

PeriodMedlineS&P 500$1,000 becomes
1 month+8.27%−3.17%$1,083
6 months+4.12%+0.11%$1,041
Year to date−9.29%+8.34%$907

Over the last 6 months it has done better than 30% of the stocks in the Healthcare sector.

Price only, without dividends.

The chart in detail

Medline: technical analysis

Medline shows no clear trend: the price and its 50- and 200-session averages are not aligned. The price is 24.6% below its all-time closing high ($49.99, February 24, 2026).

Trend
No clear trend
RSI (14 sessions)
52
Between 30 and 70
vs 200-session average
−4.15%

Support and resistance

Price areas where Medline has stopped several times in the last year. They describe the chart; they are not forecasts.

  1. Resistance$43.77+16.17%3 touches, last on July 7, 2026
  2. Resistance$42.34+12.37%2 touches, last on August 4, 2026
  3. Resistance$40.90+8.55%2 touches, last on March 27, 2026
  4. Last price$37.68
  5. Support$37.16−1.39%6 touches, last on October 16, 2026
  6. Support$35.02−7.07%3 touches, last on October 13, 2026
  7. Support$32.80−12.95%3 touches, last on August 20, 2026

Volatility and risk

Over the last year it has moved less than the S&P 500.

Beta (1 year) vs S&P 500
0.71
Volatility (60 sessions, annualised)
50.0%
Largest fall in the last year
−36.71%

Close of November 17, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it

The company

Medline and its competitors

With 45,000 employees, Medline makes and distributes medical supplies for hospitals, ambulatory surgical facilities, doctors' offices and long-term care settings in the United States and abroad. Its Medline Brand segment covers three areas: operating room and perioperative products such as surgical trays, drapes, gowns and orthopedic implants; patient-care items such as wound dressings, exam gloves, incontinence products and infection control supplies; and laboratory and diagnostic equipment, including point-of-care testing and vital signs monitors.

Headquarters
Northfield, United States
Employees
45,000
Founded
1966
Chief executive
James Boyle
Medline and its competitors
CompanyMarket capOperating marginP/E (trailing 12 months)6 months
MedlineMDLN$42.57B5.0%40.2+4.12%
ResMedRMD$33.5B34.0%21.8+17.82%
Becton, DickinsonBDX$58.96B15.7%42.8+50.15%
West Pharmaceutical ServicesWST$29.1B22.9%46.9+36.72%
SolventumSOLV$15.07B5.9%99.6+15.89%
Baxter InternationalBAX$13.41B7.6%—+48.90%

Same industry or related industries, similar size. Compare Medline with its competitors · Full profile